Course Summary
Expiration Date: 10/20/2028
The pharmacologic treatment of depression necessitates a comprehensive understanding of the historical evolution, current insights, and future trajectories of antidepressant medications. It is crucial to grasp the monoamine hypothesis and various theories regarding the pathogenesis of depression, including hypothalamic-pituitary-adrenal (HPA) axis dysregulation, neuroinflammation, and glutamate. This also encompasses knowledge of the mechanism of action, contraindications, drug interactions, and adverse effects of the different classes of currently available antidepressants. A shift towards newer treatment approaches beyond solely targeting monoamines is exemplified by the rising use of ketamine and esketamine.
Course Format
Homestudy
Course Syllabus
- Introduction
- Historical Overview
- History of the Monoamine Hypothesis
- Reserpine
- Iproniazid and INH
- Chlorpromazine and Phenothiazines
- The Monoamine Hypothesis
- Other Theories on the Pathogenesis of Depression
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation
- Neuroinflammation
- Glutamate
- Categories of Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Serotonin Norepinephrine Reuptake Inhibitors
- Tricyclic Antidepressants
- Atypical and Newer Generation Antidepressants
- Bupropion
- Mirtazapine
- Nefazodone
- Trazodone
- Vilazodone
- Vortioxetine
- Esketamine
- Withdrawal Syndrome
- Summary
Author
Dana Bartlett, RN, BSN, MSN, MA, CSPI
Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 27 years as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, textbook chapters, and more than 100 online CE articles, and done editing and reviewing for publishers such as Elsevier, Lippincott, and Thieme. He has written widely on the subject of toxicology and was a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center. He lives in Wappingers Falls, NY.
